Register for email alerts and news feeds:
This journal | BMJ Group
To SUBMIT an e-letter please go to the abstract/full text of the article and click the 'Submit a response' link in the box to the right of the text. For further help click here.

Electronic Letters to:

M Wickremasinghe, L J Ozerovitch, G Davies, T Wodehouse, M V Chadwick, S Abdallah, P Shah, and R Wilson
Non-tuberculous mycobacteria in patients with bronchiectasis
Thorax 2005; 60: 1045-1051 [Abstract] [Full text] [PDF]

Electronic letters published:

[Read eLetter] Authors' reply to Koh and Kwon
Robert Wilson   (21 December 2005)
[Read eLetter] Bronchiectasis and nontuberculous mycobacterial pulmonary infection
Won-Jung Koh, O Jung Kwon   (13 December 2005)

Authors' reply to Koh and Kwon 21 December 2005
Previous eLetter  Top
Robert Wilson,
Consultant Physician
Royal Brompton Hospital

Send letter to journal:
Re: Authors' reply to Koh and Kwon

r.wilson{at}rbh.nthames.nhs.uk Robert Wilson

Dear Editor,

We would agree with much of the content of the interesting letter from Doctors Koh and Kwon, particularly the details of M.avium complex infection and the use of CT scans in making the diagnosis.[1] We have also had experience of bronchoscopy and biopsy being necessary to make the diagnosis in some cases with suggestive radiology. The one point on which we disagree is the value of routine annual screening of sputum for AFB, and our practice of sending three samples in all patients with a deterioration in their clinical condition which is not explained or not reversed by usual treatment. The value of this practice will require a large prospective study with cost benefit analysis, and attention paid to false negative results.

However, we would argue in favour of this approach for the following reasons. Most patients have a CT scan when bronchiectasis is first suspected. Our study[2] has shown that these patients in the future may (rarely) contract NTM infection which adversely affects their condition. As Doctors Koh and Kwon state this may be insidious and go unsuspected for long periods. In our study[2] most patients with infection (rather than colonisation) had heavy bacterial load (smear positive), which would make it likely that routine screening would detect the patient. Repeat CT scans in all cases that might raise suspicion of NTM is impractical. Lastly, about 50% of cases with diffuse bronchiectasis remain idiopathic even after full investigation[3], and our understanding of NTM pathogenesis is just begining to increase. The data produced from closely studying NTM in our population of bronchiectatic patients may provide useful information in the future.

R.Wilson, M. Wickremasinghe, L.J. Ozerovitch, G. Davies, T. Wodehouse, M.V. Chadwick, S. Abdallah, P. Shah

References

(1). Hollings NP, Wells AU, Wilson R, Hansell DM Comparative appearances of non-tuberculosis mycobacteria species: a CT study Eur Radiol 2002; 12: 2211-7.

(2). Wickremasinghe M, Ozerovitch LJ, Davies G et al Non-tuberculous mycobacteria in patients with bronchiectasis Thorax 2005: 60: 1045-1051.

(3). Pasteur MC, Helliwell SM, Houghton SJ et al An investigation into causative factors in patients with bronchiectasis Am J Respir Crit Care Med 2000; 162: 1277-1284.

Bronchiectasis and nontuberculous mycobacterial pulmonary infection 13 December 2005
 Next eLetter Top
Won-Jung Koh,
Assistant Professor
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea,
O Jung Kwon

Send letter to journal:
Re: Bronchiectasis and nontuberculous mycobacterial pulmonary infection

wjkoh{at}smc.samsung.co.kr Won-Jung Koh, et al.

Dear Editor,

We read with great interest the paper by Wickremasinghe et al. on the prevalence of nontuberculous mycobacteria (NTM) in patients with bronchiectasis.[1] They showed that the prevalence of NTM was uncommon (only 2%) both in 50 newly referred patients and 50 follow up patients. However, the authors stated in the Discussion that it is now our practice to screen our patients routinely once a year because a large number of NTM isolates (28%) were detected by routine surveillance in their retrospective analysis of 71 patients with NTM sputum isolates.[1]

NTM pulmonary infection associated with bronchiectasis is increasing worldwide.[2] However, should routine periodic screening for NTM infection be necessary for all adult patients with bronchiectasis? Is sputum culture a sufficiently sensitive method to exclude active NTM infection? Are negative sputum studies sufficient to dissuade one from the diagnosis of active NTM infection?

Bronchiectasis, in general, can manifest in one of two forms: as a local or focal obstructive process of a lobe or segment of a lung or as a diffuse process involving most of the lungs.[3] In patients with diffuse bronchiectasis, the disease is more likely to be associated with specific causes, such as infection (NTM infection, Aspergillus infection), congenital conditions (primary ciliary dyskinesia, cystic fibrosis), or immunodeficiency.[3]

High-resolution computed tomography (HRCT) has proven to be a reliable and noninvasive method for the diagnosis of bronchiectasis. The pattern and distribution of abnormalities revealed by HRCT are influenced by the underlying cause of bronchiectasis. Multiple small nodules (and sometimes cavity or cavities) combined with diffuse (or widespread) bronchiectasis are reported to be the typical HRCT findings of NTM pulmonary infection associated with bronchiectasis,[4-6] which was also suggested by Wickremasinghe et al.[1] In patients with these characteristic HRCT findings, 34-50% of patients have active NTM pulmonary infection, especially M. avium complex infection.[4,6] These abnormalities are usually confined to, or most severe in, the right middle lobe and the lingular segment of the left upper lobe in NTM pulmonary infection. Therefore, this presentation is now referred to as ¡°nodular bronchiectatic disease.[2] Multiple small nodules around ecstatic bronchi on HRCT scan have been reported to represent peribronchial granuloma and caseous material.[4,5]

Diagnosis of this type of NTM pulmonary infection is often delayed; this is because symptoms are mild, and excretion of NTM in sputum is intermittent with few colonies retrievable in culture. Therefore, many patients require bronchoscopy or lung biopsy for diagnosis of NTM pulmonary disease.[7]

Therefore, in clinical practice, HRCT scans should be performed in patients with suspected bronchiectasis. NTM pulmonary infection could be suspected in selected patients who have multiple pulmonary nodules combined with diffuse bronchiectasis on HRCT scans. Multiple sputum specimens should be examined in these patients. However, the poor sensitivity of sputum cultures suggests that in that situation where multiple sputum cultures are nondiagnostic, bronchoscopy should be performed to adequately exclude or diagnose NTM pulmonary disease. We consider that there is no clear evidence to support the routine surveillance for NTM infection in all adult patients with bronchiectasis.

References

1. Wickremasinghe M, Ozerovitch LJ, Davies G, et al. Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax 2005;60:1045-51.

2. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:S1-25.

3. Barker AF. Bronchiectasis. N Engl J Med 2002;346:1383-93.

4. Tanaka E, Amitani R, Niimi A, et al. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1997;155:2041-6.

5. Jeong YJ, Lee KS, Koh WJ, et al. Nontuberculous mycobacterial pulmonary infection in immunocompetent patients: comparison of thin- section CT and histopathologic findings. Radiology 2004;231:880-6.

6. Koh WJ, Lee KS, Kwon OJ, et al. Bilateral bronchiectasis and bronchiolitis at thin-section CT: diagnostic implications in nontuberculous mycobacterial pulmonary infection. Radiology 2005;235:282-8.

7. Huang JH, Kao PN, Adi V, et al. Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. Chest 1999;115:1033-40.

Chest Medicine Jobs

Chest Medicine Jobs